VX14 809-109: A Phase 3, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 6 Through 11 Years With Cystic Fibrosis, Homozygou

Project: Research project

Project Details

StatusFinished
Effective start/end date3/26/153/26/18

Funding

  • Vertex Pharmaceuticals Incorporated
  • Vertex Pharmaceuticals Incorporated